AWA
ONC

Aaron Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Aaron Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Buy
1,267
+153
+14% +$45.1K 0.02% 524
2026
Q1 		$331K Buy
1,114
+185
+20% +$59.9K 0.02% 522
2025
Q4 		$282K Buy
929
+86
+10% +$28.1K 0.02% 585
2025
Q3 		$287K Buy
843
+15
+2% +$4.55K 0.02% 534
2025
Q2 		$200K Buy
828
+92
+13% +$22.6K 0.02% 480
2025
Q1 		$200K Buy
+736
New +$172K 0.02% 438
2022
Q2 		– Sell
-257
Closed -$48.5K – 873
2022
Q1 		$48.5K Buy
+257
New +$54.6K 0.01% 434

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Aaron Wealth Advisors's ONC Position: Q2 2026 in Review

Aaron Wealth Advisors increased its BeOne Medicines Ltd (ONC) stake by 14% in Q2 2026, buying an estimated $45.1K and bringing the position to 1,267 shares worth $361K. The position accounts for 0.02% of the portfolio, ranked #524.

Aaron Wealth Advisors first reported a position in ONC in Q1 2022 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Aaron Wealth Advisors held 1,267 shares of BeOne Medicines Ltd worth $361K as of Q2 2026.
  • Aaron Wealth Advisors bought 153 BeOne Medicines Ltd shares in Q2 2026, an estimated $45.1K.
  • BeOne Medicines Ltd made up 0.02% of Aaron Wealth Advisors's portfolio in Q2 2026, its #524 holding.
  • Aaron Wealth Advisors first reported a position in BeOne Medicines Ltd in Q1 2022 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.